- Home
- ELDN vs POWW Comparison
ELDN vs POWW Comparison
Compare ELDN & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- POWW
- Stock Information
- Founded
- ELDN 2004
- POWW 1990
- Country
- ELDN United States
- POWW United States
- Employees
- ELDN N/A
- POWW N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- ELDN Health Care
- POWW Industrials
- Exchange
- ELDN Nasdaq
- POWW Nasdaq
- Market Cap
- ELDN 202.4M
- POWW 167.5M
- IPO Year
- ELDN N/A
- POWW N/A
- Fundamental
- Price
- ELDN $2.37
- POWW $1.43
- Analyst Decision
- ELDN Strong Buy
- POWW Buy
- Analyst Count
- ELDN 2
- POWW 2
- Target Price
- ELDN $12.50
- POWW $1.75
- AVG Volume (30 Days)
- ELDN 640.2K
- POWW 454.6K
- Earning Date
- ELDN 11-11-2025
- POWW 08-08-2025
- Dividend Yield
- ELDN N/A
- POWW N/A
- EPS Growth
- ELDN N/A
- POWW N/A
- EPS
- ELDN 0.21
- POWW N/A
- Revenue
- ELDN N/A
- POWW $45,280,898.00
- Revenue This Year
- ELDN N/A
- POWW $8.25
- Revenue Next Year
- ELDN N/A
- POWW $0.74
- P/E Ratio
- ELDN $11.10
- POWW N/A
- Revenue Growth
- ELDN N/A
- POWW 76.12
- 52 Week Low
- ELDN $2.32
- POWW $0.95
- 52 Week High
- ELDN $5.54
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- ELDN 35.17
- POWW 51.24
- Support Level
- ELDN $2.41
- POWW $1.40
- Resistance Level
- ELDN $2.84
- POWW $1.64
- Average True Range (ATR)
- ELDN 0.13
- POWW 0.08
- MACD
- ELDN 0.00
- POWW -0.01
- Stochastic Oscillator
- ELDN 10.48
- POWW 12.50
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.